■ Published papers
|
Original article
|
|
1.
|
Tadahiko Shien, Makoto Ishitobi, Keita Sasaki, Kiyo Tanaka, Akihiko Shimomura, Takahiro Tsukioki, Yasuaki Sagara, Yuri Kimura, Kaori Terata, Takayuki Ishiba, Hiroyuki Yasojima, Makiko Ono, Kyoko Goda, Yoichi Naito, Tomomi Fujisawa, Fumikata Hara, Gakuto Ogawa, Haruhiko Fukuda, Hiroji Iwata,：
Efficacy and prognostic predictors of primary systemic therapy for de novo Stage IV breast cancer. Exploratory analysis of JCOG1017 PRIM-BC.
Breast cancer (Tokyo, Japan)
33
(2)
：396-406
, 2026.3
DOI:10.1007/s12282-025-01821-4
|
|
2.
|
Yonemori K, Shimoi T, Yamamoto K, Kogawa T, Kitano S, Kobayashi S, Yanai K, Yamaguchi K, Otake Y, Hojo S, Ono M：
Phase I study of H3B-6545 in patients with estrogen receptor-positive breast cancer.
ESMO Open
10
(6)
：105290
, 2025.6
|
|
3.
|
Yamashige, D., Hijioka, S., Nagashio, Y., Maruki, Y., Fukuda, S., Yagi, S., Okamoto, K., Hara, H., Hagiwara, Y., Agarie, D., Takasaki, T., Ohba, A., Kondo, S., Morizane, C., Ueno, H., Sone, M., Saito, Y., Okusaka, T.：
Potential of 6-mm-diameter fully covered self-expandable metal stents for unresectable malignant distal biliary obstruction: a propensity score-matched study.
Clin Endosc
58
：121-133
, 2025
DOI:10.5946/ce.2024.044
|
|
4.
|
Ono M, Takahashi I, Kudo T, Miyazaki N, Azuma T, Horinouchi H, Kinoshita I, Nakajima TE, Yoshino T, Minami H：
Barriers to career development and gender-related challenges in oncology: the results of the JSMO and JSCO surveys in Japan.
ESMO Real World Data and Digital Oncology
：不明
, 2025
|
|
5.
|
Kondo, S., Kitano, S., Sato, J., Katsuya, Y., Kogawa, T., Mizugaki, H., Miyamoto, I., Iwasawa, S., Imaizumi, T., Tomita, H., Murakami, C., Miyake, T., Yamamoto, N.：
An investigation of extended-interval dosing of atezolizumab in Japanese patients with advanced solid tumors: safety and pharmacokinetics of a dose of 1680 mg every 4 weeks.
Invest New Drugs
：1-7
, 2025
DOI:10.1007/s10637-024-01498-0
|
|
6.
|
Miyamoto I, Kogawa T, Kurokawa K, Miyawaki E, Arihara Y, Fukuoka S, Ozaki Y, Ono M, Yunokawa M, Yamazaki M, Hayashi N, Fukada I, Ueno T, Takahashi S, Kitano S：
Clinical potential of antibody–drug conjugates in early-phase clinical trials for late-line treatment of advanced solid tumors.
Investigational New Drugs
：不明
, 2025
|
|
7.
|
Giordano A, Awan AA, Bruce JY, Rugo HS, Diamond JR, Novik Y, Baranda J, Muro K, Ono M, Nanda R, Kaplan J, Gorla S, Liu S, Wozniak M, Poondru S, Dillon R, Meng C, Traina T：
Enfortumab vedotin in patients with previously treated advanced breast cancer in the Phase 2 EV-202 study.
JCO Oncology Advances
：不明
, 2025
|
|
Display 5 items
|
|
Display all(7)
|
|
Review article
|
|
1.
|
Hikari Sano, Hideyuki Hayashi, Naomi Nakao, Hiroko Hosoi, Shunsuke Kondo：
Expanding indications and developmental landscape of HER2-targeted therapies in breast cancer: a pharmacotherapeutic perspective.
Expert opinion on pharmacotherapy
：2025 Nov 16
, 2025.11
DOI:10.1080/14656566.2025.2591813
|
|
Case report
|
|
1.
|
Nakano Kenji, Oki Ryosuke, Wang Xiaofei, Nakao Takehiro, Fukuda Naoki, Urasaki Tetsuya, Ono Makiko, Tomomatsu Junichi, Miura Yuji, Sato Yukiko, Yamashita Kyoko, Takeuchi Kengo, Hayashi Naomi, Fukada Ippei, Mitani Hiroki, Takahashi Shunji, Kenji Nakano：
NTRK-rearranged soft tissue sarcoma that originated from the head and neck with a robust response to the TRK inhibitor larotrectinib.
International cancer conference journal
15
(1)
：147-153
, 2026.1
DOI:10.1007/s13691-025-00832-4
|
|
2.
|
Fukuda N, Toda K, Chiba T, Fukada I, Mori S, Tonooka A, Toda E, Yoshida J, Wang X, Oki R, Nakao T, Urasaki T, Nakano K, Ono M, Tomomatsu J, Takeuchi K, Takahashi S, Miura Y：
Sporadic medullary thyroid carcinoma with a rare RET transmembrane domain (A641R) mutation that respond to selpercatinib: a case report with review of literature.
The Oncologist
：oyaf209
, 2025.7
DOI:10.1093/oncolo/oyaf209
|
|
To the top
|
|
